The role of Asprosin in patients with dilated cardiomyopathy

Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of ener...

Source: BMC Cardiovascular Disorders - September 7, 2020 Category: Cardiology Authors: Ming-Shien Wen, Chao-Yung Wang, Jih-Kai Yeh, Chun-Chi Chen, Ming-Lung Tsai, Ming-Yun Ho, Kuo-Chun Hung and I-Chang Hsieh Tags: Research article Source Type: research